Key result
Hysterectomy, salpingo-oophorectomy, and chemotherapy yield no recurrence at 10 months in one epithelioid angiosarcoma patient.
Why the study?
Uterine mesenchymal tumors other than leiomyosarcoma, carcinosarcoma, and endometrial stromal sarcomas are extremely uncommon, warranting detailed case reports and literature review.
Case Report (n=1)
This case report describes a rare instance of epithelioid angiosarcoma arising from a uterine leiomyoma, successfully managed with surgery and adjuvant chemotherapy.
May guide management of rare uterine epithelioid angiosarcoma; leaves open optimal regimens and long-term outcomes.
Uterine mesenchymal tumors other than leiomyosarcoma, carcinosarcoma, and endometrial stromal sarcomas are extremely uncommon. We describe a case of epithelioid angiosarcoma of the uterus and review previous literature on such rare tumors. A 48-year-old woman presented with a 1-year history of abdominal fullness and 10kg weight loss. Pelvic magnetic resonance imaging (MRI) revealed a huge (30×18cm) uterus accompanied by degeneration and necrosis. She underwent supracervical hysterectomy and right salpingo-oophorectomy. We postoperatively diagnosed the mass as an epithelioid angiosarcoma arising from a leiomyoma. Vasodilatation was observed within the range of 2 cm × several mm in the leiomyoma, and proliferation of atypical cells was observed covering the surface of the luminal side. The tumor showed a partly fine vascular structure and was associated with obvious nuclear atypia and mitotic figures. She received 6 courses of adjuvant chemotherapy with paclitaxel, epirubicin, and carboplatin, and there have been no signs of recurrence for 10 months.
No takes yet. Share an insight, caveat, or question.
Hara et al. (2018) conducted a case report in Epithelioid angiosarcoma arising from a leiomyoma (n=1). Supracervical hysterectomy, right salpingo-oophorectomy, and adjuvant chemotherapy was evaluated on Recurrence. Supracervical hysterectomy, right salpingo-oophorectomy, and 6 courses of adjuvant chemotherapy resulted in no signs of recurrence at 10 months in a patient with epithelioid angiosarcoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: